Latest / The BioHub - by Avetix
Episode 131 - Dipal Doshi - CEO of Entrada Therapeutics
Today, we’re joined by Dipal Doshi, a leader at theforefront of modern biotechnology and rare disease innovation. As CEO of Entrada Therapeutics, Dipal has helped build the company from its earliest days into a clinical-stage pioneer focused on unlocking intracellular therapies.
With a career that spans investment banking at MerrillLynch, global pharma at Eli Lilly and Company, and senior leadership roles at Amicus Therapeutics, Dipal brings a unique blend of financial, strategic, and commercial expertise to the biotech world.
Now Dipal's leading Entrada Therapeutics, who are aclinical-stage…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.